At the heart of BISC’s transformative potential lies its remarkably small form factor and its exceptional data transmission speed. Unlike traditional implantable systems that often involve bulky canisters of electronics requiring significant surgical intervention, the BISC implant is a single, integrated circuit chip. This chip is so thin – measuring just 50 micrometers – that it can be seamlessly placed in the subdural space, the area between the brain and the skull, resting on the brain’s surface with minimal disturbance, akin to a piece of wet tissue paper. This unprecedented miniaturization, achieved through advanced semiconductor manufacturing techniques, drastically reduces surgical invasiveness and the risk of tissue damage and signal degradation.

The architecture of BISC, detailed in a recent publication in Nature Electronics, comprises three key components: the chip-based implant itself, a wearable external "relay station," and the sophisticated software platform that orchestrates their interaction. Professor Ken Shepard of Columbia University, a senior author and leader of the engineering efforts, highlighted the stark contrast between BISC and existing technologies. "Most implantable systems are built around a canister of electronics that occupies enormous volumes of space inside the body," Shepard explained. "Our implant is a single integrated circuit chip that is so thin that it can slide into the space between the brain and the skull, resting on the brain like a piece of wet tissue paper." This single-chip approach integrates a multitude of complex electronic functions, including a radio transceiver, wireless power circuitry, digital control electronics, power management systems, data converters, and the analog components essential for both recording neural activity and delivering targeted stimulation.

Dr. Andreas S. Tolias, a professor at Stanford University and co-corresponding author, emphasized BISC’s role in transforming the brain’s cortex into a high-bandwidth interface. "BISC turns the cortical surface into an effective portal, delivering high-bandwidth, minimally invasive read-write communication with AI and external devices," Tolias stated. His extensive experience in training artificial intelligence systems on large-scale neural recordings, including those collected with BISC, has been instrumental in assessing the implant’s ability to decode brain activity with remarkable accuracy. The scalability of this single-chip design opens doors for adaptive neuroprosthetics and brain-AI interfaces capable of treating a wide range of neuropsychiatric disorders, with epilepsy being a prime example.

The clinical perspective is equally enthusiastic. Dr. Brett Youngerman, assistant professor of neurological surgery at Columbia University and a neurosurgeon at NewYork-Presbyterian/Columbia University Irving Medical Center, served as the project’s lead clinical collaborator. "This high-resolution, high-data-throughput device has the potential to revolutionize the management of neurological conditions from epilepsy to paralysis," he asserted. Youngerman, alongside Shepard and Dr. Catherine Schevon, an epilepsy neurologist at NewYork-Presbyterian/Columbia, has already secured a National Institutes of Health grant to investigate BISC’s efficacy in treating drug-resistant epilepsy. He further elaborated on the core advantages of BISC: "The key to effective brain-computer interface devices is to maximize the information flow to and from the brain, while making the device as minimally invasive in its surgical implantation as possible. BISC surpasses previous technology on both fronts." The integration of advanced semiconductor technology, which has condensed the computing power of room-sized computers into pocket-sized devices, is now being applied to medical implantables, allowing complex electronics to reside within the body with minimal spatial footprint.

The engineering behind BISC represents a significant leap forward in BCI technology. Traditional medical-grade BCIs typically employ multiple discrete microelectronic components, necessitating a larger implanted unit and often requiring more invasive surgical procedures to house these components or route wires to the brain. BISC, in contrast, consolidates all necessary functionalities onto a single complementary metal-oxide-semiconductor (CMOS) integrated circuit. This chip, thinned to an astonishing 50 micrometers, occupies less than 1/1000th the volume of a standard implant, with a total volume of approximately 3 cubic millimeters. Its flexible nature allows it to conform to the intricate surface of the brain. This micro-electrocorticography (µECoG) device is equipped with an impressive 65,536 electrodes, enabling 1,024 recording channels and 16,384 stimulation channels. Crucially, its production utilizing established semiconductor industry manufacturing methods ensures its suitability for large-scale, cost-effective production.

The external relay station plays a vital role in powering the implant and facilitating high-speed data communication. It utilizes a custom ultrawideband radio link, achieving a remarkable throughput of 100 megabits per second, which is at least 100 times faster than any other wireless BCI currently available. Operating as an 802.11 WiFi device, the relay station seamlessly bridges the implant to any external computer, enabling sophisticated real-time data processing. BISC also incorporates its own instruction set and a comprehensive software environment, effectively creating a specialized computing system tailored for brain interfaces. The high-bandwidth recording capabilities of BISC allow for the processing of brain signals by advanced machine-learning and deep-learning algorithms, paving the way for the interpretation of complex intentions, perceptual experiences, and brain states. As Shepard aptly put it, "By integrating everything on one piece of silicon, we’ve shown how brain interfaces can become smaller, safer, and dramatically more powerful."

The advanced semiconductor fabrication of the BISC implant utilizes TSMC’s 0.13-µm Bipolar-CMOS-DMOS (BCD) technology. This sophisticated manufacturing process integrates three distinct semiconductor technologies onto a single chip, enabling the efficient co-existence of digital logic (CMOS), high-current and high-voltage analog functions (bipolar and DMOS transistors), and power devices (DMOS). This synergistic combination is critical for BISC’s exceptional performance and miniaturization.

The transition from laboratory research to clinical application is well underway. Shepard’s team has collaborated closely with Dr. Youngerman at NewYork-Presbyterian/Columbia University Irving Medical Center to develop surgical procedures for safely implanting the thin device in preclinical models. These studies have yielded high-quality, stable recordings, and short-term intraoperative studies in human patients are already being conducted. "These initial studies give us invaluable data about how the device performs in a real surgical setting," Youngerman noted. "The implants can be inserted through a minimally invasive incision in the skull and slid directly onto the surface of the brain in the subdural space. The paper-thin form factor and lack of brain-penetrating electrodes or wires tethering the implant to the skull minimize tissue reactivity and signal degradation over time."

Extensive preclinical work in the motor and visual cortices has been performed in collaboration with Dr. Tolias and Dr. Bijan Pesaran, a professor at the University of Pennsylvania and a recognized leader in computational and systems neuroscience. Dr. Pesaran commented on the significance of BISC’s miniaturization: "The extreme miniaturization by BISC is very exciting as a platform for new generations of implantable technologies that also interface with the brain with other modalities such as light and sound." The development of BISC was supported by the Defense Advanced Research Projects Agency (DARPA) through its Neural Engineering System Design program, leveraging Columbia’s expertise in microelectronics, Stanford and Penn’s advanced neuroscience programs, and NewYork-Presbyterian/Columbia University Irving Medical Center’s surgical capabilities.

To accelerate the commercialization of this transformative technology, researchers from Columbia and Stanford have founded Kampto Neurotech. This startup, led by Dr. Nanyu Zeng, a former lead engineer on the BISC project, is focused on producing research-ready versions of the chip and securing funding for human clinical trials. "This is a fundamentally different way of building BCI devices," Zeng stated. "In this way, BISC has technological capabilities that exceed those of competing devices by many orders of magnitude."

As artificial intelligence continues its rapid evolution, BCIs are emerging as a critical technology, not only for restoring lost functions in individuals with neurological disorders but also for potentially enhancing human capabilities through direct brain-to-computer communication. Shepard envisions a future where the seamless interaction between the brain and AI systems can profoundly benefit humanity. "By combining ultra-high resolution neural recording with fully wireless operation, and pairing that with advanced decoding and stimulation algorithms, we are moving toward a future where the brain and AI systems can interact seamlessly — not just for research, but for human benefit," he concluded. "This could change how we treat brain disorders, how we interface with machines, and ultimately how humans engage with AI."